Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Yhdessä selviytyminen: paripohjaiset interventiot syöpää varten (CCST2)

perjantai 13. marraskuuta 2026 päivittänyt: Duke University

Parin kommunikointitaitojen koulutus edistyneille syöville

The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST effects on a range of patient and partner relationship and psychological outcomes.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

For patients and their intimate partners, advanced cancer poses significant challenges that can negatively impact both individuals and the couple's collective well-being. Couples' ability to communicate openly and effectively with each other about cancer-related concerns can improve their psychological adjustment and quality of their relationship. Open and effective communication may also lead to better symptom management and goal-concordant care. However, many couples report difficulties communicating about cancer, even in the context of overall satisfying relationships. This can have a number of deleterious consequences, including deficits in emotional support, decreases in intimacy and relationship quality, and increased psychological distress. Thus, interventions designed to facilitate effective communication between cancer patients and their partners are likely to have beneficial effects on both individual and relationship functioning.

Prior research, including studies conducted by our team, has found that couple-based interventions that target communication lead to positive outcomes for cancer patients and their partners. However, most prior studies have been limited by reliance on an in-person treatment delivery format which keeps many couples from participating. In addition, prior studies have not targeted interventions to couples who are most likely to benefit. There is increasing evidence that psychosocial interventions for cancer, including couple-based interventions, should be targeted to those at risk of poor outcomes. Our prior research indicates that couples who report communication difficulties (e.g., high levels of holding back from discussing cancer-related concerns) have increased psychological distress and poorer relationship functioning and are most likely to benefit from a couple communication intervention specifically designed to addressed their communication problems.

The specific aims of this study are (1)To determine whether CCST significantly improves patients' and partners' individual psychological adjustment (i.e., psychological distress, life completion) and patient health and health care outcomes (physical well-being, symptom distress, advance care planning discussions and completion of advance directives, hospitalizations, and emergency department visits) compared to an education condition. (2) To determine whether, for couples receiving the CCST intervention, improvements in psychological adjustment, relationship functioning, and patient health are mediated by improvements in their communication, including objective measures of communication quality and communal coping (e.g., "we-talk") derived from couple conversations and self-reported protective buffering. (3) To examine differences in response to the CCST intervention for patients versus partners, for male versus female participants, and for patients with different cancer diagnoses (breast, lung, GI, GU). (4) To conduct an implementation-related process evaluation of the intervention.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

440

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • North Carolina
      • Durham, North Carolina, Yhdysvallat, 27705
        • Duke University Medical Center

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  1. Married or in a committed intimate relationship
  2. Diagnosis of one the following advanced cancers: Stage IIIB or IV non-small cell lung cancer or extensive stage small cell lung cancer, Stage III pancreatic cancer or Stage IV GI cancer, Stage IV GU cancer, Stage IV breast cancer and GYN cancer Stage III-IV ovarian, IV uterine, IV cervical.
  3. Both members of the couple must speak and read English.
  4. Patient and/or partner scores >=1.0 on the Holding Back screen.

Exclusion Criteria:

  1. Patient lacks capacity for interview (documented diagnosis of active psychosis or dementia) or is unable to provide informed consent as assessed by research staff.
  2. Patient has a life expectancy < 6 months as estimated by his/her treating oncologist.
  3. Patient or partner is physically impaired in such a way that precludes the use of a computer or videoconferencing.
  4. Patient or partner is too sick to participate, as judged by the oncologist or research staff.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Muut: Couple Communication and Support

CCST includes components to assist couples in communicating effectively, decreasing avoidance of important cancer-related issues, and providing each other with support. It includes training in skills for sharing one's thoughts and feelings and listening to one's partner and responding in a supportive manner, and joint problem solving. Participants will be asked to participate inactivities at home between sessions to strengthen skills acquisition.

Participants attend six 60-minute sessions consisting of education and skills training to enhance cancer-related communication.

Muut nimet:
  • CCST
Muut: Healthy Lifestyle Informaion

Healthy Lifestyle Information provides couples with health information relevant to cancer in a supportive environment. Sessions focus on the following topics: fatigue, sleep disturbance, nutrition, physical activity, survivorship care plans, and palliative care. Patients and partners are invited to discuss their experiences around the session topics with the therapist and ask questions about the information presented.

Participants attend attend six 60-minute sessions consisting of information and support across a range of cancer-related topics.

Muut nimet:
  • HLI

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Changes in patient relationship functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient relationship functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner relationship functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient life completion measured by the Life Completion scale of the QUAL-E (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in partner psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in partner life completion measured by the Life Completion scale of the QUAL-E Family (higher scores indicate higher completion)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient physical well being as measured by the Physical Well Being subscale of the Functional Assessment of Cancer Therapy scale (higher scores indicate higher physical well being)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient and partner psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in symptom distress as measured by the Condensed Memorial Symptom Assessment Scale (higher scores indicate higher symptom distress)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient advance care planning discussions (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient completion of advanced directives (presence or absence, via patient self-report)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient hospitalizations (number of hospitalizations per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
Changes in patient psychological functioning
Aikaikkuna: Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Change in patient emergency department visits (number of emergency department visits per patient self-report, validated by medical record review)

Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Tutkijat

  • Päätutkija: Laura Porter, PhD, Duke

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Tiistai 20. lokakuuta 2020

Ensisijainen valmistuminen (Todellinen)

Keskiviikko 31. joulukuuta 2025

Opintojen valmistuminen (Todellinen)

Keskiviikko 31. joulukuuta 2025

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 9. lokakuuta 2020

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 15. lokakuuta 2020

Ensimmäinen Lähetetty (Todellinen)

Maanantai 19. lokakuuta 2020

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 17. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 13. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • Pro00103232

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa